| Natural compounds as potential inhibitors of SARS-CoV-2 main protease: An: in-silico: study A Mishra, Y Pathak, A Kumar, SK Mishra, V Tripathi Asian Pacific Journal of Tropical Biomedicine 11 (4), 155-163, 2021 | 38 | 2021 |
| Rifampicin and Letermovir as potential repurposed drug candidate for COVID-19 treatment: insights from an in-silico study Y Pathak, A Mishra, G Choudhir, A Kumar, V Tripathi Pharmacological Reports 73 (3), 926-938, 2021 | 20 | 2021 |
| Rifampicin may be repurposed for COVID-19 treatment: Insights from an in-silico study Y Pathak, A Mishra, V Tripathi | 15 | 2020 |
| Targeting notch signaling pathway in breast cancer stem cells through drug repurposing approach Y Pathak, I Camps, A Mishra, V Tripathi Molecular Diversity 27 (6), 2431-2440, 2023 | 5 | 2023 |
| Pathogenic role of iNOs+ M1 effector macrophages in fibromyalgia V Tripathi, A Mishra, Y Pathak, A Jain, H Prakash Macrophages, 2021 | 5 | 2021 |
| Anticancer natural compounds as potential inhibitors of novel coronavirus (COVID19) main protease: An in-silico study A Mishra, Y Pathak, G Choudhir, A Kumar, SK Mishra, V Tripathi Cancer Research 81 (13_Supplement), 712-712, 2021 | 4 | 2021 |
| Triamcinolone as a Potential Inhibitor of SARS-CoV-2 Main Protease and Cytokine Storm: An In silico Study A Mishra, F Abul Qais, Y Pathak, I Camps, V Tripathi Letters in Drug Design & Discovery 20 (9), 1230-1242, 2023 | 3 | 2023 |
| Natural compounds as a potential modifier of stem cells renewal: Comparative analysis A Mishra, Y Pathak, SK Mishra, H Prakash, V Tripathi European Journal of Pharmacology 938, 175412, 2023 | 2 | 2023 |
| History, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) A Mishra, N Nair, V Tripathi, Y Pathak, J Majeed Coronaviruses 3 (1), 65-72, 2022 | 1 | 2022 |
| Plant-Derived Polyphenols in Modulating the Immune Response against COVID-19 A Mishra, K Shivangi, M Yadav, D Sharma, J Upadhyay, Y Pathak, ... Anti-SARS-CoV-2 Activity of Flavonoids, 140-151, 2024 | | 2024 |
| Lumacaftor as a potential repurposed drug in targeting breast cancer stem cells: insights from in silico study Y Pathak, I Camps, M Yadav, A Mishra, J Upadhyay, V Tripathi Journal of Molecular Modeling 30 (7), 227, 2024 | | 2024 |
| In-silico Identification of Dexamethasone-similar Compounds Against SARS-Cov-2 Spike Protein: A Drug Repurposing Approach Y Pathak, V Tripathi, I Camps, FA Qais, A Mishra Letters in Organic Chemistry 21 (5), 414-424, 2024 | | 2024 |
| In-silico Screening Of Dietary Polyphenols To Target Cxc Motif Chemokine Ligand 12 In Breast Cancer A Mishra, Y Pathak, M Chaudhary, V Tripathi TISSUE ENGINEERING PART A 28, 386-387, 2022 | | 2022 |
| Pathogenic Role of iNOs+ M1 Effector Macrophages in Fibromyalgia A Mishra, Y Pathak, A Jain, V Tripathi, H Prakash Macrophages, 2020 | | 2020 |
| MDA-7/IL-24: A Promising Cytokine in Cancer Therapy A Mishra, Y Pathak, R Kumar, A Kumar, S Kirti MED CAL SCIENCES, 15, 2020 | | 2020 |
